Business Description
Genflow Biosciences plc is a UK and Belgium-based biotechnology company focused on developing gene therapies designed to slow the aging process and reduce diseases that come with age. Founded in 2020 and headquartered in London, the company is currently in the pre-clinical stage, working on a range of treatments that target aging at a biological level, including therapies for muscle loss, skin aging, and eye conditions. Its most advanced candidate delivers a modified gene directly into the bloodstream, while other programs explore applications in both human health and veterinary care.
